Erlotinib Terminated Phase 3 Trials for Recurrent Non-Small Cell Lung Carcinoma / Metastatic Malignant Neoplasm in the Brain / Tumors Metastatic to Brain / Stage IV Non-Small Cell Lung Cancer / Non-Small Cell Lung Cancer Recurrent / Stage IV Non-Small Cell Lung Cancer AJCC v7 Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00096265Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer